Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,895 | 153 | 96.6% |
| Education | $103.38 | 3 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $464.48 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $420.86 | 23 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $384.31 | 13 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $232.52 | 11 | $0 (2024) |
| Indivior Inc. | $229.40 | 14 | $0 (2024) |
| ITI, Inc. | $219.17 | 14 | $0 (2023) |
| ABBVIE INC. | $216.60 | 17 | $0 (2024) |
| Corium, LLC | $124.78 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $103.56 | 6 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $101.50 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,099 | 110 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($464.48) |
| 2023 | $899.42 | 46 | ITI, Inc. ($219.17) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/25/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: ADHD | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: CNS | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Neuropsychiatry | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.39 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Neuropsychiatry | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $123.17 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 24 | $4,660 | $799.93 |
| 2022 | 4 | 64 | 77 | $9,255 | $3,263 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,405 | $405.91 | 16.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,255 | $394.02 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $4,255 | $1,383 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $2,255 | $833.34 | 37.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 19 | 19 | $1,425 | $657.78 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $1,320 | $389.28 | 29.5% |
About Stephanie Macklin
Stephanie Macklin is a Physician Assistant healthcare provider based in Raeford, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2022. The National Provider Identifier (NPI) number assigned to this provider is 1003545773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Macklin has received a total of $2,999 in payments from pharmaceutical and medical device companies, with $2,099 received in 2024. These payments were reported across 156 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,895).
As a Medicare-enrolled provider, Macklin has provided services to 88 Medicare beneficiaries, totaling 101 services with total Medicare billing of $4,063. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Raeford, NC
- Active Since 06/08/2022
- Last Updated 04/22/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1003545773
Products in Payments
- CAPLYTA (Drug) $683.65
- INGREZZA (Drug) $384.31
- REXULTI (Drug) $256.67
- VRAYLAR (Drug) $216.60
- PERSERIS (Drug) $196.16
- Qelbree (Drug) $189.70
- ABILIFY MAINTENA (Drug) $130.34
- Azstarys (Drug) $124.78
- TRINTELLIX (Drug) $103.56
- Auvelity (Drug) $91.35
- LOREEV XR (Drug) $88.84
- HETLIOZ (Drug) $87.82
- COBENFY (Drug) $76.93
- LYBALVI (Drug) $56.04
- SPRAVATO (Drug) $43.98
- QELBREE (Drug) $42.82
- INVEGA SUSTENNA (Drug) $41.64
- SUBLOCADE (Drug) $33.24
- ARISTADA (Drug) $28.00
- ABILIFY ASIMTUFII (Drug) $23.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Raeford
Mr. Brian Rose, Pac, PAC
Physician Assistant — Payments: $53,818
Ms. Zena Kobaissi, Pa-C, PA-C
Physician Assistant — Payments: $2,358
Mr. James Taylor, Pa, PA
Physician Assistant — Payments: $1,311
Jennifer Wilson, Pa-C, PA-C
Physician Assistant — Payments: $984.43
William Shilkitus, Pac, PAC
Physician Assistant — Payments: $952.80
Mrs. Raquel Mccann, Pa-C, PA-C
Physician Assistant — Payments: $939.62